CSL Limited CSL Limited

CSL Limited

CSL

Rang in aandelen #363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Aandeelprijs
$138.75
Marktkapitalisatie
$66.58B
Verandering (1 dag)
0.08%
Verandering (1 jaar)
-3.02%
Land
AU
Handel CSL Limited (CSL)

Categorie

Healthcare
Aandelsplitsingen voor CSL Limited (CSL)
Het aandeel CSL Limited (symbool: CSL) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op Oct 18, 2007.
Eén aandeel CSL dat vóór Oct 18, 2007 werd gekocht, staat nu gelijk aan 3 aandelen CSL.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2007-10-18 3:1 x3 x3
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 1 x100
BE